Piperacillin/tazobactamCandida lipolytica infection and off-label use

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2008卷 / 1期

关键词：

D O I：

10.1007/s40278-024-59188-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：294 / 294

相关论文

共 50 条

[1] Off-label use of piperacillin/tazobactam (Zosyn®) in a pediatric unit
Thaker, DJ
Wilson, JP
Browne, BA
Godley, PJ
[J]. VALUE IN HEALTH, 2004, 7 (03) : 353 - 353
[2] RituximabUrinary tract infection and off-label use
[J]. Reactions Weekly, 2024, 2016 (1) : 437 - 437
[3] Off-label use of antipsychotics: Rethinking "off-label"
Groleger, Urban
[J]. PSYCHIATRIA DANUBINA, 2007, 19 (04) : 350 - 353
[4] Dexamethasone/piperacillin/tazobactamLack of efficacy following off-label use: case report
[J]. Reactions Weekly, 2021, 1867 (1) : 153 - 153
[5] Dexamethasone/piperacillin/tazobactam/remdesivirLack of efficacy and off-label use: case report
[J]. Reactions Weekly, 2023, 1956 (1) : 184 - 184
[6] Metformin/piperacillin/tazobactam/propacetamolLack of efficacy and off-label use: case report
[J]. Reactions Weekly, 2022, 1911 (1) : 272 - 272
[7] Cefepime/piperacillin/tazobactamDevelopment of drug resistance and off-label use: case report
[J]. Reactions Weekly, 2023, 1943 (1) : 192 - 192
[8] Off-label use in cardiac surgery ["Off-label use" in der Herzchirurgie]
Fenger H.
Löher A.
Sindermann J.R.
Scheld H.H.
Schmidt C.
Hoffmeier A.
[J]. Zeitschrift für Herz-,Thorax- und Gefäßchirurgie, 2009, 23 (6) : 345 - 348
[9] Off-label use and G-BA. Legal framework for off-label use
Brucklacher, U.
Brockmeyer, N. H.
Riedel, C.
[J]. HAUTARZT, 2013, 64 (10): : 736 - 742
[10] RituximabBorrelia infection following off-label use: case report
[J]. Reactions Weekly, 2021, 1853 (1) : 421 - 421

← 1 2 3 4 5 →